212 related articles for article (PubMed ID: 19271158)
1. [Rectal cancer. How much radiotherapy do surgery patients need?].
Ulrich A; Weitz J; Büchler MW
Chirurg; 2009 Apr; 80(4):266-73. PubMed ID: 19271158
[TBL] [Abstract][Full Text] [Related]
2. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
3. New aspects of adjuvant radiotherapy in primarily resectable rectal cancer.
Budach W
Onkologie; 2002 Jun; 25(3):223-30. PubMed ID: 12119456
[TBL] [Abstract][Full Text] [Related]
4. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer].
Rödel C; Sauer R; Fietkau R
Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930
[TBL] [Abstract][Full Text] [Related]
5. [Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].
Sauer J; Sobolewski K; Dommisch K
Zentralbl Chir; 2009 Sep; 134(5):450-4. PubMed ID: 19757345
[TBL] [Abstract][Full Text] [Related]
6. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
[TBL] [Abstract][Full Text] [Related]
7. [Fiction and facts about multi-modal therapy in rectal cancer].
Ulrich A; Weitz J; Friess H; Büchler M
Zentralbl Chir; 2006 Apr; 131(2):134-9. PubMed ID: 16612780
[TBL] [Abstract][Full Text] [Related]
8. [Rectal carcinoma--oncologically adequate resection].
Simon D
Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoradiation in rectal cancer: why we need a common language.
Glynne-Jones R
Onkologie; 2005 May; 28(5):237-40. PubMed ID: 15934137
[No Abstract] [Full Text] [Related]
10. Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision.
Colquhoun P; Wexner SD; Cohen A
J Surg Oncol; 2003 Jul; 83(3):133-9. PubMed ID: 12827680
[No Abstract] [Full Text] [Related]
11. Abdominoperineal resection for rectal cancer at a specialty center.
Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy-associated morbidity and mortality in rectal surgery].
Kulu Y; Büchler MW; Ulrich A
Chirurg; 2013 Nov; 84(11):951-6. PubMed ID: 24170116
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma].
Sauer R; Rödel C
Praxis (Bern 1994); 2002 Sep; 91(37):1476-84. PubMed ID: 12360683
[TBL] [Abstract][Full Text] [Related]
14. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication].
Junginger T; Hermanek P; Oberholzer K; Schmidberger H
Zentralbl Chir; 2006 Aug; 131(4):275-84. PubMed ID: 17004186
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary management of early-stage rectal cancer.
Phillips JG; Hong TS; Ryan DP
J Natl Compr Canc Netw; 2012 Dec; 10(12):1577-85. PubMed ID: 23221792
[TBL] [Abstract][Full Text] [Related]
16. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S;
BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382
[TBL] [Abstract][Full Text] [Related]
17. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ;
Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621
[TBL] [Abstract][Full Text] [Related]
18. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
19. Resectable rectal cancer: which patient does not need preoperative radiotherapy?
Kulu Y; Ulrich A; Büchler MW
Dig Dis; 2012; 30 Suppl 2():118-25. PubMed ID: 23207943
[TBL] [Abstract][Full Text] [Related]
20. Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer.
Pacelli F; Di Giorgio A; Papa V; Tortorelli AP; Covino M; Ratto C; Bossola M; Valentini V; Sofo L; Miccichè F; Gambacorta MA; Doglietto GB
Dis Colon Rectum; 2004 Feb; 47(2):170-9. PubMed ID: 15043286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
